Track the 온코닉테라퓨틱스 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 온코닉테라퓨틱스 has published 30 reports. Market capitalisation: €532.4bn. The latest transaction was filed on 3 July 2026 (Other). Among the most active insiders: 신종길. The full history is openly available.
30
Insider Decl.
0
Thresholds
€205,917
15 ops.
Buy Volume
€8m
2 ops.
Sell Volume
22Σ signal
Buys €205,917€8m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,565 of 26,212 companies
66.2
score / 100
Value
37
Quality
96
FCF yld2.1%
Earn yld3.0%
EV/EBITDA36.8x
ROE29%
Gross mgn100%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Onconic Therapeutics is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments for various diseases.